Baidu
map

内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

2018 JBDS-IP指南：糖尿病住院患者的自我管理

2018-06-19 英国糖尿病协会联合住院治疗组 Diabet Med. 2018 Jun 19.

糖尿病住院患者自我管理

2018年6月，英国糖尿病协会联合住院治疗组(JBDS-IP)发布了糖尿病住院患者的自我管理指南，文章主要目的是通过有效的自我管理提高住院糖尿病患者的经验和安全性。指南主要内容涉及糖尿病自我管理的原理，糖尿病专家小组的作用，自我管理的标准，患者教育，血糖管理等。

中文标题：

2018 JBDS-IP指南：糖尿病住院患者的自我管理

英文标题：

Self-management of diabetes in hospital: a guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care group.

发布机构：

英国糖尿病协会联合住院治疗组

发布日期：

2018-06-19

简要介绍：

2018年6月，英国糖尿病协会联合住院治疗组(JBDS-IP)发布了糖尿病住院患者的自我管理指南，文章主要目的是通过有效的自我管理提高住院糖尿病患者的经验和安全性。指南主要内容涉及糖尿病自我管理的原理，糖尿病专家小组的作用，自我管理的标准，患者教育，血糖管理等。 

拓展指南：与糖尿病相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 JBDS-IP指南：糖尿病住院患者的自我管理)] GetToolGuiderByIdResponse(projectId=1, id=61de01c001606236, title=2018 JBDS-IP指南：糖尿病住院患者的自我管理, enTitle=Self-management of diabetes in hospital: a guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care group., guiderFrom=Diabet Med. 2018 Jun 19., authorId=null, author=, summary=2018年6月，英国糖尿病协会联合住院治疗组(JBDS-IP)发布了糖尿病住院患者的自我管理指南，文章主要目的是通过有效的自我管理提高住院糖尿病患者的经验和安全性。指南主要内容涉及糖尿病自我管理的原理，糖尿病专家小组的作用，自我管理的标准，患者教育，血糖管理等。 , cover=, journalId=null, articlesId=null, associationId=1453, associationName=英国糖尿病协会联合住院治疗组, associationIntro=, copyright=0, guiderPublishedTime=Tue Jun 19 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>2018年6月，英国糖尿病协会联合住院治疗组(JBDS-IP)发布了糖尿病住院患者的自我管理指南，文章主要目的是通过有效的自我管理提高住院糖尿病患者的经验和安全性。指南主要内容涉及糖尿病自我管理的原理，糖尿病专家小组的作用，自我管理的标准，患者教育，血糖管理等。 </div> <div><br> </div>拓展指南：<strong>与<font color=red>糖尿病</font>相关指南：</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=0ba401c001603883" title="糖尿病检验诊断报告模式专家共识" target=_blank>糖尿病检验诊断报告模式专家共识</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=6f8a11c0016025f4" title="老年人糖尿病前期干预指南" target=_blank>老年人糖尿病前期干预指南</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=bb86e1c001601155" title="2018 营养和饮食学会循证实践指南：妊娠糖尿病" target=_blank>2018 营养和饮食学会循证实践指南：妊娠糖尿病</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=c75bb1c001593e29" title="2018年AACE/ACE《2型糖尿病综合管理策略》更新与解读" target=_blank>2018年AACE/ACE《2型糖尿病综合管理策略》更新与解读</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=7fd571c001585823" title="2型糖尿病起始胰岛素后方案转换的临床指导建议" target=_blank>2型糖尿病起始胰岛素后方案转换的临床指导建议</a></li> 更多信息请点击：<a href="//m.capotfarm.com/guideline/list.do?q=%E7%B3%96%E5%B0%BF%E7%97%85" target=_blank>有关糖尿病更多指南</a></ul>, tagList=[TagDto(tagId=216, tagName=糖尿病), TagDto(tagId=2665, tagName=住院患者), TagDto(tagId=18102, tagName=自我管理)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7879, appHits=386, showAppHits=0, pcHits=4850, showPcHits=3580, likes=145, shares=11, comments=6, approvalStatus=1, publishedTime=Sun Jun 24 00:00:01 CST 2018, publishedTimeString=2018-06-19, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Jun 24 00:00:01 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 18:35:46 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 JBDS-IP指南：糖尿病住院患者的自我管理)])
2018 JBDS-IP指南：糖尿病住院患者的自我管理
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=336676, encodeId=66493366e63d, content=值得学习，学习进步, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c33e2412978, createdName=1237db7em74暂无昵称, createdTime=Sun Aug 05 19:43:13 CST 2018, time=2018-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326603, encodeId=7fc8326603f9, content=好好文章学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Sun Jun 24 10:55:24 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326526, encodeId=dc3a326526dd, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Jun 24 07:16:27 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326524, encodeId=fe76326524b4, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Sun Jun 24 07:14:23 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326503, encodeId=a54032650322, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sun Jun 24 05:26:44 CST 2018, time=2018-06-24, status=1, ipAttribution=)]
    2018-08-05 1237db7em74暂无昵称

    值得学习，学习进步

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=336676, encodeId=66493366e63d, content=值得学习，学习进步, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c33e2412978, createdName=1237db7em74暂无昵称, createdTime=Sun Aug 05 19:43:13 CST 2018, time=2018-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326603, encodeId=7fc8326603f9, content=好好文章学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Sun Jun 24 10:55:24 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326526, encodeId=dc3a326526dd, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Jun 24 07:16:27 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326524, encodeId=fe76326524b4, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Sun Jun 24 07:14:23 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326503, encodeId=a54032650322, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sun Jun 24 05:26:44 CST 2018, time=2018-06-24, status=1, ipAttribution=)]
    2018-06-24 139****5926

    好好文章学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=336676, encodeId=66493366e63d, content=值得学习，学习进步, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c33e2412978, createdName=1237db7em74暂无昵称, createdTime=Sun Aug 05 19:43:13 CST 2018, time=2018-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326603, encodeId=7fc8326603f9, content=好好文章学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Sun Jun 24 10:55:24 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326526, encodeId=dc3a326526dd, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Jun 24 07:16:27 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326524, encodeId=fe76326524b4, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Sun Jun 24 07:14:23 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326503, encodeId=a54032650322, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sun Jun 24 05:26:44 CST 2018, time=2018-06-24, status=1, ipAttribution=)]
    2018-06-24 1dd8c52fm63(暂无匿称)

    了解了解.学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=336676, encodeId=66493366e63d, content=值得学习，学习进步, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c33e2412978, createdName=1237db7em74暂无昵称, createdTime=Sun Aug 05 19:43:13 CST 2018, time=2018-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326603, encodeId=7fc8326603f9, content=好好文章学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Sun Jun 24 10:55:24 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326526, encodeId=dc3a326526dd, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Jun 24 07:16:27 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326524, encodeId=fe76326524b4, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Sun Jun 24 07:14:23 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326503, encodeId=a54032650322, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sun Jun 24 05:26:44 CST 2018, time=2018-06-24, status=1, ipAttribution=)]
    2018-06-24 yjs木玉

    好好好好好好好好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=336676, encodeId=66493366e63d, content=值得学习，学习进步, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c33e2412978, createdName=1237db7em74暂无昵称, createdTime=Sun Aug 05 19:43:13 CST 2018, time=2018-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326603, encodeId=7fc8326603f9, content=好好文章学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Sun Jun 24 10:55:24 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326526, encodeId=dc3a326526dd, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Jun 24 07:16:27 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326524, encodeId=fe76326524b4, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Sun Jun 24 07:14:23 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326503, encodeId=a54032650322, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sun Jun 24 05:26:44 CST 2018, time=2018-06-24, status=1, ipAttribution=)]
    2018-06-24 神功盖世

    阅

    0

相关指南

糖尿病检验诊断报告模式专家共识

世界华人检验与病理医师协会 · 2018-06-12

2018 波兰糖尿病患者管理指南

波兰糖尿病学会(PTD,Polskie Towarzystwo Diabetologiczne) · 2018-01-30

2018 年ADA糖尿病医学诊疗标准解读

暂未更新 · 2018-01-30

中国2型糖尿病自我管理处方专家共识 （2017年版）

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2017-12-30

ADA 关于糖尿病合并高血压的最新立场声明的解读

暂未更新 · 2017-10-30

糖尿病患者血糖波动管理专家共识

中华医学会内分泌学分会(CSE,Chinese Society of Endocrinology) · 2017-09-15

Baidu
map
Baidu
map
Baidu
map